The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteers

The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials

(2012) Peer C. Tfelt-Hansen et al.   JOURNAL OF HEADACHE AND PAIN

Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers

(2011) Faisal Mohammad Amin et al.   CEPHALALGIA

Emerging migraine treatments and drug targets

(2011) Jes Olesen et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Evidence for a vascular factor in migraine

(2010) Mohammad S. Asghar et al.   ANNALS OF NEUROLOGY

Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers

(2010) M. S. Asghar et al.   NEUROLOGY

Does sumatriptan cross the blood–brain barrier in animals and man?

(2009) Peer Carsten Tfelt-Hansen   JOURNAL OF HEADACHE AND PAIN

The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs

(2009) Carlos M. Villalón et al.   PHARMACOLOGY & THERAPEUTICS